US Bancorp’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-389,142
Closed -$374K 4168
2023
Q2
$374K Hold
389,142
﹤0.01% 1555
2023
Q1
$292K Hold
389,142
﹤0.01% 1690
2022
Q4
$143K Hold
389,142
﹤0.01% 2037
2022
Q3
$167K Hold
389,142
﹤0.01% 1943
2022
Q2
$304K Buy
+389,142
New +$343K ﹤0.01% 1690
2021
Q4
Sell
-625
Closed -$1K 4269
2021
Q3
$1K Sell
625
-386
-38% -$1.05K ﹤0.01% 4044
2021
Q2
$4K Buy
+1,011
New +$3.51K ﹤0.01% 3696
2020
Q2
Sell
-998
Closed -$2K 3925
2020
Q1
$2K Buy
998
+939
+1,592% +$2.57K ﹤0.01% 3504
2019
Q4
$0 Sell
59
-242
-80% -$1.96K ﹤0.01% 3756
2019
Q3
$2K Buy
301
+3
+1% +$24 ﹤0.01% 3453
2019
Q2
$3K Buy
298
+176
+144% +$1.57K ﹤0.01% 3410
2019
Q1
$1K Sell
122
-1,151
-90% -$12.3K ﹤0.01% 3541
2018
Q4
$11K Sell
1,273
-537
-30% -$6.84K ﹤0.01% 3016
2018
Q3
$30K Sell
1,810
-1,351
-43% -$29.2K ﹤0.01% 2788
2018
Q2
$66K Buy
3,161
+800
+34% +$14.8K ﹤0.01% 2438
2018
Q1
$38K Buy
+2,361
New +$46.8K ﹤0.01% 2734
2016
Q3
Sell
-46
Closed 3641
2016
Q2
$0 Buy
+46
New +$325 ﹤0.01% 3667
2013
Q3
Sell
-661
Closed -$5K 3354
2013
Q2
$5K Buy
+661
New +$5.07K ﹤0.01% 3019

US Bancorp's SPPI Position: Q3 2023 in Review

US Bancorp sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 389,142 shares — an estimated $374K sold.

US Bancorp first reported a position in SPPI in Q2 2013 and held it in 18 quarters. The position peaked at $374K in Q2 2023. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • US Bancorp reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • US Bancorp sold 389,142 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $374K.
  • US Bancorp first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
  • US Bancorp's Spectrum Pharmaceuticals Inc position peaked at $374K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.